Literature DB >> 3000532

Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture.

H Bigalke, F Dreyer, G Bergey.   

Abstract

The effects of botulinum A neurotoxin and tetanus toxin were studied in cultured mouse spinal cord neurons. In approximately 60% of the neurons (n = 150), botulinum A neurotoxin caused paroxysmal depolarizing events. In two cells hyperpolarizing shifts were observed. The pattern of the burst-like activity varied in shape and frequency in individual cells. Between the paroxysmal events, ongoing synaptic activity could be recorded. The other 40% of the treated neurons did not develop a characteristic pattern of bursts, but there was a decrease in frequency of synaptically generated events. In contrast to botulinum A neurotoxin, tetanus toxin invariably produced well organized paroxysmal events without any synaptic activity between them. At later stages botulinum A neurotoxin and tetanus toxin blocked inhibitory and excitatory postsynaptic potentials in all neurons studied. These results have demonstrated, for the first time using electrophysiological techniques, that botulinum A neurotoxin blocks both excitatory and inhibitory synaptic transmission in the mammalian central nervous system. There are however differences between these effects of botulinum A neurotoxin and the actions of tetanus toxin on these cells. It is suggested that at the femtomolar range tetanus toxin blocks selectively central inhibitory systems and botulinum A neurotoxin the motor endplate. At the picomolar range both toxins affect many if not all, transmitter systems.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000532     DOI: 10.1016/0006-8993(85)91248-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Botulism with sensory symptoms: a second case.

Authors:  J C Martínez-Castrillo; M A Del Real; A Hernandez Gonzalez; G De Blas; J C Alvarez-Cermeño
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells.

Authors:  P Marxen; F Bartels; G Ahnert-Hilger; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

Review 5.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 6.  Progress in cell based assays for botulinum neurotoxin detection.

Authors:  Sabine Pellett
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations.

Authors:  Sabine Pellett; William H Tepp; Eric A Johnson
Journal:  FEBS Lett       Date:  2019-07-04       Impact factor: 4.124

Review 8.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

9.  Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal.

Authors:  E A Neale; L M Bowers; M Jia; K E Bateman; L C Williamson
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

10.  Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.

Authors:  Veronica A Antipova; Carsten Holzmann; Oliver Schmitt; Andreas Wree; Alexander Hawlitschka
Journal:  Front Behav Neurosci       Date:  2017-06-21       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.